PT2117533E - Composição farmacêutica à base de stachytarpheta sp., processo para a sua obtenção e sua utilização no tratamento de vitiligo - Google Patents

Composição farmacêutica à base de stachytarpheta sp., processo para a sua obtenção e sua utilização no tratamento de vitiligo Download PDF

Info

Publication number
PT2117533E
PT2117533E PT07815757T PT07815757T PT2117533E PT 2117533 E PT2117533 E PT 2117533E PT 07815757 T PT07815757 T PT 07815757T PT 07815757 T PT07815757 T PT 07815757T PT 2117533 E PT2117533 E PT 2117533E
Authority
PT
Portugal
Prior art keywords
stachytarpheta
obtaining
basis
pharmaceutical composition
same
Prior art date
Application number
PT07815757T
Other languages
English (en)
Inventor
Emerson Queiroz Ferreira
Original Assignee
Aché Laboratórios Farmac Uticos S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aché Laboratórios Farmac Uticos S A filed Critical Aché Laboratórios Farmac Uticos S A
Publication of PT2117533E publication Critical patent/PT2117533E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/85—Verbenaceae (Verbena family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Cosmetics (AREA)
PT07815757T 2007-02-15 2007-11-14 Composição farmacêutica à base de stachytarpheta sp., processo para a sua obtenção e sua utilização no tratamento de vitiligo PT2117533E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BRPI0700767A BRPI0700767B8 (pt) 2007-02-15 2007-02-15 composição farmacêutica, produto farmaceutico, processo para obtenção de compostos farmaceuticos e uso de tais compostos para o tratamento do vitiligo

Publications (1)

Publication Number Publication Date
PT2117533E true PT2117533E (pt) 2015-03-10

Family

ID=39689569

Family Applications (1)

Application Number Title Priority Date Filing Date
PT07815757T PT2117533E (pt) 2007-02-15 2007-11-14 Composição farmacêutica à base de stachytarpheta sp., processo para a sua obtenção e sua utilização no tratamento de vitiligo

Country Status (16)

Country Link
US (6) US20100028400A1 (pt)
EP (1) EP2117533B1 (pt)
JP (1) JP5443174B2 (pt)
AR (1) AR065365A1 (pt)
BR (1) BRPI0700767B8 (pt)
CA (1) CA2678407C (pt)
CL (1) CL2008000484A1 (pt)
CO (1) CO6220946A2 (pt)
DK (1) DK2117533T3 (pt)
ES (1) ES2531759T3 (pt)
MX (1) MX2009008799A (pt)
PL (1) PL2117533T3 (pt)
PT (1) PT2117533E (pt)
SI (1) SI2117533T1 (pt)
UY (1) UY30920A1 (pt)
WO (1) WO2008098325A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0700767B8 (pt) * 2007-02-15 2021-05-25 Ache Laboratorios Farmaceuticos Sa composição farmacêutica, produto farmaceutico, processo para obtenção de compostos farmaceuticos e uso de tais compostos para o tratamento do vitiligo
BR102017003318A2 (pt) * 2017-02-17 2018-10-30 Aché Laboratórios Farmacêuticos S.A. compostos, processo de produção de compostos, extrato enriquecido, frações ativas de extrato enriquecido, processo de produção de extrato enriquecido, método de seleção de biomassa vegetal para produção de extrato enriquecido, composição e uso para tratamento de desordens imunológicas

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5174253A (ja) 1974-12-24 1976-06-28 Sharp Kk Teidenatsusochi
JP3627068B2 (ja) * 1995-03-29 2005-03-09 日本メナード化粧品株式会社 育毛剤
IT1317732B1 (it) * 2000-01-20 2003-07-15 Giuliani Spa Composti ad attivita' antiossidante, composizioni utili qualiintegratori alimentari che li contengono e procedimento per
EP1145709A1 (de) * 2000-04-14 2001-10-17 Laboratoires Serobiologiques Verwendung von Naturstoffen zur Herstellung von kosmetischen Zubereitungen
US6753017B2 (en) * 2001-11-07 2004-06-22 Jrs Pharma Lp Process for preparing dry extracts
US20040077556A1 (en) * 2002-04-22 2004-04-22 Robert Chinery Compositions and methods for promoting weight loss, thermogenesis, appetite suppression, lean muscle mass, increasing metabolism and boosting energy levels, and use as a dietary supplement in mammals
FR2848117B1 (fr) 2002-12-10 2006-08-04 Roche Consumer Health Ltd Procede de preparation d'un extrait de centella asiatica riche en madecassoside et en terminoloside
BRPI0406343A (pt) * 2004-11-16 2006-08-01 Marcal De Queiroz Paulo fitomedicamento para repigmentação da pele - vitiligo
EP1736167B1 (en) * 2005-06-20 2018-03-21 I.R.B. Istituto Di Ricerche Biotecnologiche S.r.l. Extracts obtained from cell line cultures from Syringa vulgaris IRB-SV25/B (DMS:16857), their preparation and use
US7399783B2 (en) * 2005-06-22 2008-07-15 The Quigley Corporation Methods for the treatment of scar tissue
AR059545A1 (es) * 2006-02-28 2008-04-09 Bayer Consumer Care Ag Combinacion de verbacosido y luteolina
BRPI0700767B8 (pt) 2007-02-15 2021-05-25 Ache Laboratorios Farmaceuticos Sa composição farmacêutica, produto farmaceutico, processo para obtenção de compostos farmaceuticos e uso de tais compostos para o tratamento do vitiligo

Also Published As

Publication number Publication date
US10813970B2 (en) 2020-10-27
US20130287868A1 (en) 2013-10-31
US10813971B2 (en) 2020-10-27
BRPI0700767A (pt) 2008-09-30
CA2678407A1 (en) 2008-08-21
US20180071356A1 (en) 2018-03-15
PL2117533T3 (pl) 2015-06-30
JP2010518127A (ja) 2010-05-27
DK2117533T3 (en) 2015-03-09
ES2531759T3 (es) 2015-03-18
AR065365A1 (es) 2009-06-03
CO6220946A2 (es) 2010-11-19
WO2008098325A1 (en) 2008-08-21
US20190134136A1 (en) 2019-05-09
EP2117533A4 (en) 2010-08-04
UY30920A1 (es) 2008-09-02
US20180071357A1 (en) 2018-03-15
BRPI0700767B8 (pt) 2021-05-25
BRPI0700767B1 (pt) 2020-09-15
MX2009008799A (es) 2009-10-28
SI2117533T1 (sl) 2015-05-29
US20100028400A1 (en) 2010-02-04
US20220000961A1 (en) 2022-01-06
EP2117533A1 (en) 2009-11-18
CL2008000484A1 (es) 2008-09-05
JP5443174B2 (ja) 2014-03-19
CA2678407C (en) 2021-08-31
EP2117533B1 (en) 2014-12-03

Similar Documents

Publication Publication Date Title
EP2151500A4 (en) BRANCHED A-GLUCAN, THESE PRODUCING A-GLUCOSYLTRANSFERASE, METHOD FOR THE PRODUCTION THEREOF AND USE THEREOF
ZA201000588B (en) Improved pharmaceutical-coated medical products,the production thereof and the use thereof
ZA201001015B (en) (Carboxylalkylene-phenyl)-phenyl-oxalamides, method for the production thereof, and use of same as a medicament
IL204556A (en) (Cyclopropyl - phenyl) - Phenyl - oxalamides, a method for their production, and their use as a drug
HK1171456A1 (en) 17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl derivatives, methods for the production thereof and use thereof for treating diseases 17--17---49(10)--11-
IL207811A0 (en) Kit, composition, product or medicament for treating cognitive impairment
HK1110097A1 (en) Lactobacillus fermenti, cms-h002 and its applying
EP2199446A4 (en) ALUMINUM FIBER MATERIAL, METHOD FOR PRODUCING THE SAME, AND USE
PT2225314T (pt) Silicones-autoadesivos, método de fabrico, complexos que os utilizam e aplicações
EP2266619A4 (de) Pharmazeutische zusammensetzung auf basis eines leberschützenden mittels und eines präbiotischen mittels, ihre herstellung und verwendung
AP2010005435A0 (en) 1,4-Naphthoquinone derivatives and therapeutic usethereof.
EP2292241A4 (en) SCUTELLARIN DERIVATIVE PRODUCTION, PREPARATION, PHARMACEUTICAL COMPOSITION AND ITS USE
GB2450812B (en) Compound, ink, process and use
GB0708531D0 (en) Process, compound, ink and use
PL2117533T3 (pl) Kompozycja farmaceutyczna na bazie stachytarpheta sp., proces jej otrzymywania oraz jej zastosowanie do leczenia bielactwa
EP2086316A4 (en) SUBUNGUICIDE, AND METHOD FOR TREATING ONYCHOMYCOSIS
GB0612029D0 (en) Compound, ink, process and use
IL226362A0 (en) compounds, and methods for treating cancer
ZA201005396B (en) 17-hydroxy-19-nor-21-carboxylic acid-steroid y-lactone derivative,use thereof,and medicament containing the derivative
GB0719834D0 (en) Compounds, method and use
GB0922009D0 (en) Compound, ink, process and use
GB0603605D0 (en) Process, compounds and their uses
GB0800844D0 (en) Process for making up or caring for keratin materials, comprising the application of compounds A, B and C.
ZA200810175B (en) Amino-imidazolones and their use as a medicament for treating cognitive impairment. Alzheimer disease, neurode-generation and dementia
GB0710580D0 (en) Process, compound, ink and use